Beranda300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Tutup sebelumnya
¥15,59
Rentang hari
¥15,31 - ¥15,67
Rentang tahun
¥13,10 - ¥21,12
Kapitalisasi pasar
17,49 M CNY
Volume Rata-Rata
12,41 jt
Rasio P/E
-
Hasil dividen
0,58%
Bursa utama
SHE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 671,38 jt | -17,74% |
Biaya operasional | 425,29 jt | -2,76% |
Penghasilan bersih | 11,62 jt | -93,74% |
Margin laba bersih | 1,73 | -92,40% |
Penghasilan per saham | — | — |
EBITDA | 212,79 jt | -40,14% |
Tarif pajak efektif | -3.472,08% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,65 M | 431,20% |
Total aset | 14,13 M | -2,63% |
Total liabilitas | 4,52 M | -5,87% |
Total ekuitas | 9,61 M | — |
Saham yang beredar | 1,12 M | — |
Harga terhadap nilai buku | 1,81 | — |
Tingkat pengembalian aset | 2,39% | — |
Tingkat pengembalian modal | 2,94% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 11,62 jt | -93,74% |
Kas dari operasi | 286,87 jt | 60,54% |
Kas dari investasi | 676,05 jt | 357,44% |
Kas dari pembiayaan | -44,23 jt | -4,17% |
Perubahan kas bersih | 918,51 jt | 825,91% |
Arus kas bebas | -1,08 M | 43,85% |
Tentang
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Didirikan
8 Sep 1992
Situs
Karyawan
1.913
